Chengcheng HUANG, Ke PANG, Hongli GAO. Clinical characteristics of coronavirus disease 2019 in a Chongqing hospital: analysis of 89 cases[J]. Journal of Third Military Medical University, 2020, 42(9): 883-886.
DOI:
Chengcheng HUANG, Ke PANG, Hongli GAO. Clinical characteristics of coronavirus disease 2019 in a Chongqing hospital: analysis of 89 cases[J]. Journal of Third Military Medical University, 2020, 42(9): 883-886. DOI: 10.16016/j.1000-5404.202002143.
Clinical characteristics of coronavirus disease 2019 in a Chongqing hospital: analysis of 89 cases
To analyze the clinical characteristics of 89 cases of coronavirus disease 2019 (COVID-19) in Yongchuan Hospital of Chongqing Medical University.
Methods
2
The epidemiological data
clinical symptoms and results of laboratory tests of 89 COVID-19 patients admitted in our hospital from January 22 to February 17 2020 were collected and retrospectively analyzed.
Results
2
Fever and cough were the main
symptoms of COVID-19
but there were 6 asymptomatic carriers in the cohort. The severe group had significantly lower lymphocyte absolute value
lymphocyte percentage
and the counts of CD3
+
CD4
+
and CD8
+
cells when compared with the ordinary group (
P
<
0.05). The severe group also had obviously high levels of C-reactive protein and IL-6 than the ordinary and mild groups (
P
<
0.05). The severity of the disease was positively correlated with age
type 2 diabetes
C-reactive protein and IL-6 levels
and negatively correlated with the counts of lymphocytes
CD3
+
CD4
+
and CD8
+
cells. Multivariate Logistic regression analysis indicated that increased C-reactive protein and decreased CD8
+
cell count were independent factors for the severity of the condition.
Conclusion
2
Fever and cough are the main symptoms of COVID-19. C-reactive protein and CD8
+
cell count are helpful for the assessment of the disease
and immune function is closely related to the severity of the disease.
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team of Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China[J]. Chin J Epidemiol, 2020, 41(2): 145-151. DOI: 10.3760/cma.j.issn.0254-6450.2020.02.003.
National Health Commission. Diagnosis and treatment of pneumonia caused by new coronavirus infection (trial version 5)[J]. Chin J Integr Trad West Med, 2020: 1-3. DOI:10.7661/j.cjim.20200202.064.
WU F, ZHAO S, YU B, et al . A new coronavirus associated with human respiratory disease in China[J ] . Nature, 2020, 579(7798): 1-8. DOI:10.1038/s41586-020-2008-3.
[Branch of Pediatrics of Chinese Medical Association. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first in terim edition)[J ] . Chin J Pediatr, 2020, 58(3): 169-174.DOI: 10.3760/cma.j.issn.0578-1310.2020.03.001 http://dx.doi.org/10.3760/cma.j.issn.0578-1310.2020.03.001 .
DU Y H, JIN C W, YANG J, et al . Preliminary study of clinical and CT manifestations of family-associated early new-type coronavirus pneumonia[J ] . J Xi'an Jiaotong Univ (Med Edition), 2020, 41(2): 215.
PREGLEJ T, HAMMINGER P, LUU M, et al . Histone deacetylases 1 and 2 restrain CD4 + cytotoxic T lymphocytedifferentiation[J ] . JCI Insight, 2020, 5(4): 133393. DOI:10.1172/jci.insight.133393..
STENGER S, HANSON D A, TEITELBAUM R, et al . An antimicrobial activity of cytolytic T cells mediated by granulysin[J ] . Science, 1998, 282(5386): 121-125. DOI:10.1126/science.282.5386.121.
CHEN W W, XIE Y X, ZHANG Y H, et al . Changes and analysis of peripheral white blood cells and lymphocyte subsets for patients with p andemic influenza A virus (H1N1) infection[J ] . Chin J Exp Clin Virol, 2010, 24(5): 331-333. DOI:10.3760/cma.j.issn.1003-9279.2010.05.004.
ZHAO Y, ZHANG Y H, DENNEY L, et al . High levels of virus-specific CD4 + T cells predict severe pandemic influenza A virus infection[J ] . Am J Respir Crit Care Med, 2012, 186(12): 1292-1297. DOI:10.1164/rccm.201207-1245OC..
HIGDON M M, LE T, O'BRIEN K L, et al . Association of C-reactive protein with bacterial and respiratory syncytial virus-associated pneumonia among children aged 5 years in the PERCH study[J ] . Clin Infect Dis, 2017, 64(suppl_3): S378-S386. DOI:10.1093/cid/cix150.